A sophisticated diagnostic method for determining the quantity of hepatitis B virus (HBV) DNA in a patient’s blood sample is the Hepatitis B Virus DNA PCR (Quantitative) test. In order to identify and measure the viral DNA, this test uses polymerase chain reaction (PCR) technology. This allows for the monitoring of treatment efficacy as well as the provision of important data regarding the degree of HBV infection.The addition of “health heart diagnostics” (HHD) to the HBV DNA PCR test’s description highlights the test’s wider applicability than liver health, especially with regard to cardiovascular health. An elevated risk of cardiovascular conditions such as atherosclerosis, myocardial infarction, and stroke is linked to persistent hepatitis B infection. Chronic HBV infection can cause ongoing inflammation and immune system activation, which can lead to endothelial dysfunction, plaque development,